Evidence map›Paper›PMID 27102573›Full record

ArticleTropical medicine & international health : TM & IH2016

Ethical challenges in designing and conducting medicine quality surveys.

Patricia Tabernero, Michael Parker, Raffaella Ravinetto, Souly Phanouvong, Shunmay Yeung, Freddy E Kitutu, Phaik Yeong Cheah, Mayfong Mayxay, Philippe J Guerin, Paul N Newton

Abstract read
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patricia TaberneroLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.
Michael ParkerThe Ethox Centre, University of Oxford, Oxford, UK.
Raffaella RavinettoDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Souly PhanouvongUnited States Pharmacopeia, Promoting the Quality of Medicines Program, United States Pharmacopeial Convention, Rockville, MD, USA.
Shunmay YeungDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Freddy E KitutuPharmacy Department and School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Phaik Yeong CheahCentre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.
Mayfong MayxayLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.
Philippe J GuerinWorldWide Antimalarial Resistance Network, Oxford, UK.
Paul N NewtonLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.

Funding

Wellcome Trust
6 · The paper itself

Abstract

objectivesIn this paper we discuss the main ethical challenges related to the conduct of medicine quality surveys and make suggestions on how to address them.

methodMost evidence-based information regarding medicine quality derives from surveys. However, existing research ethical guidelines do not provide specific guidance for medicine quality surveys. Hence, those conducting surveys are often left wondering how to judge what counts as best practice. A list of the main ethical challenges in the design and conduct of surveys is presented. RESULTS AND

conclusionsIt is vital that the design and conduct of medicine quality surveys uphold moral and ethical obligations and analyse the ethical implications and consequences of such work. These aspects include the impact on the local availability of and access to medicines; the confidentiality and privacy of the surveyors and the surveyed; questions as to whether outlet staff personnel should be told they are part of a survey; the need of ethical and regulatory approvals; and how the findings should be disseminated. Medicine quality surveys should ideally be conducted in partnership with the relevant national Medicine Regulatory Authorities. An international, but contextually sensitive, model of good ethical practice for such surveys is needed.

Indexed as

Ethics, ResearchSurveys and QuestionnairesHumansPharmaceutical PreparationsVaccinesPharmaceutical PreparationsVaccinescontrefaçoncounterfeitencuestasethicséthiqueéticafalsificaciónfalsified and substandard medicinesmala calidadmauvaise qualitémedicamentosmedicamentos falsificados y subestándarmédicamentsmédicaments falsifiés et de qualité inférieuremedicinespoor qualitysurveillancessurveys

Identifiers

PMID27102573
PMCPMC4913736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.